Medirom Healthcare Technologies Stock Today

MRM Stock  USD 0.90  0.02  2.27%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 64

 
High
 
Low
Quite High
Medirom Healthcare is selling at 0.9 as of the 30th of January 2025; that is 2.27 percent increase since the beginning of the trading day. The stock's lowest day price was 0.88. Medirom Healthcare has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
29th of December 2020
Category
Consumer Cyclical
Classification
Health Care
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. The company has 7.9 M outstanding shares of which 22.68 K shares are now shorted by investors with about 0.71 days to cover. More on Medirom Healthcare Technologies

Moving together with Medirom Stock

  0.9CI Cigna Corp Earnings Call TomorrowPairCorr
  0.63MD Mednax IncPairCorr

Moving against Medirom Stock

  0.77ECOR Electrocore LLCPairCorr
  0.77VVOS Vivos TherapeuticsPairCorr
  0.66DXCM DexCom Inc Earnings Call This WeekPairCorr
  0.58ELMD ElectromedPairCorr
  0.58EMBC Embecta CorpPairCorr
  0.55GH Guardant HealthPairCorr

Medirom Stock Highlights

Thematic IdeaPersonal Services (View all Themes)
Old NameMMA Offshore Ltd
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Consumer Cyclical, ASX Small Ordinaries, NASDAQ Composite, SPASX 300, Personal Services, Health Care, Health Care Providers & Services, Personal Services, Consumer Cyclical (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.690.9
Way Down
Slightly volatile
Gross Profit Margin0.260.2298
Moderately Up
Slightly volatile
Net Debt2.3 B4.1 B
Way Down
Very volatile
Total Current Liabilities3.2 B4.1 B
Significantly Down
Slightly volatile
Non Current Liabilities Total2.9 B3.5 B
Significantly Down
Slightly volatile
Total Assets6.3 B7.9 B
Significantly Down
Slightly volatile
Total Current Assets1.8 BB
Moderately Down
Slightly volatile
Debt Levels
Medirom Healthcare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Medirom Healthcare's financial leverage. It provides some insight into what part of Medirom Healthcare's total assets is financed by creditors.
Liquidity
Medirom Healthcare Technologies has 3.65 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Medirom to invest in growth at high rates of return.

Change In Working Capital

602.25 Million
Medirom Healthcare Technologies (MRM) is traded on NASDAQ Exchange in USA. It is located in Tradepia Odaiba, Tokyo, Japan, 135-0091 and employs 390 people. Medirom Healthcare is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a total capitalization of 7.08 M. Medirom Healthcare runs under Health Care Providers & Services sector within Health Care industry. The entity has 7.9 M outstanding shares of which 22.68 K shares are now shorted by investors with about 0.71 days to cover. Medirom Healthcare Technologies has about 354.95 M in cash with (631.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Medirom Healthcare Probability Of Bankruptcy
Ownership Allocation
Medirom Healthcare Technologies holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Medirom Ownership Details

Medirom Stock Institutional Holders

InstituionRecorded OnShares
Ubs Group Ag2024-09-30
18 K
Virtu Financial Llc2024-09-30
10.9 K
Bank Of America Corp2024-09-30
25.0
View Medirom Healthcare Diagnostics

Medirom Healthcare Historical Income Statement

At this time, Medirom Healthcare's Reconciled Depreciation is very stable compared to the past year. As of the 30th of January 2025, Income Before Tax is likely to grow to about 24.9 M, though Net Interest Income is likely to grow to (30.6 M). View More Fundamentals

Medirom Stock Against Markets

When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.582
Earnings Share
(0.15)
Revenue Per Share
1.4 K
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.04)
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.